Check out our most popular compounded medications! Get Started
Oxybutynin Chloride 7.5 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the active ingredient over an extended period, providing sustained therapeutic effects. This formulation is used to treat conditions such as Overactive Bladder, Urinary Incontinence, Neurogenic Detrusor Overactivity, Nocturnal Enuresis, and Urge Incontinence. The slow release mechanism reduces dosing frequency and improves patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Oxybutynin Chloride 7.5 mg Slow Release Capsules are a compounded formulation designed to treat a variety of conditions such as overactive bladder, urinary incontinence, and urinary frequency. This formulation is uniquely designed with Methocel E4M, a controlled-release polymer, which allows for a gradual release of the encapsulated medication over an extended period of time. This slow release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications requiring a controlled and prolonged release profile.
It is crucial to note that this formulation is contraindicated in patients with glaucoma, urinary retention, or uncontrolled narrow-angle glaucoma. Patients should be made aware of potential side effects, which may include dry mouth, constipation, blurred vision, and dizziness. It is of utmost importance that the medication is taken as prescribed and the recommended dosage is not exceeded.
Healthcare providers prescribing Oxybutynin Chloride 7.5 mg Slow Release Capsules should be cognizant of the contraindications and potential side effects. Regular monitoring of patients for signs of adverse effects is recommended. This includes symptoms such as dry mouth, constipation, blurred vision, and dizziness.
At Bayview Pharmacy, we are dedicated to providing the highest quality of care to our patients. We encourage any questions or concerns regarding Oxybutynin Chloride 7.5 mg Slow Release Capsules to be directed to our team. We are here to ensure your medication needs are met with the utmost care and precision.
Oxybutynin Chloride 7.5 mg Slow Release Capsules are a specialized formulation designed for the treatment of overactive bladder, characterized by symptoms such as urge urinary incontinence, urgency, and frequency. The medication functions by reducing muscle spasms in the bladder and enhancing its capacity. The capsules are formulated with Methocel E4M, a controlled-release polymer, which ensures the gradual release of the active ingredient over an extended period. This slow release mechanism offers sustained therapeutic effects, reduces the need for frequent dosing, and improves patient compliance, particularly for medications that require a controlled and prolonged release profile.
However, it is crucial to note that this medication is not suitable for patients with untreated narrow-angle glaucoma, urinary retention, or gastric retention. Potential side effects may include drowsiness, dizziness, blurred vision, dry mouth, constipation, and difficulty urinating. Additionally, this medication may cause an increase in heart rate and blood pressure. Patients experiencing any of these side effects should promptly inform their healthcare provider.
Furthermore, Oxybutynin Chloride 7.5 mg Slow Release Capsules may interact with other medications such as anticholinergics, antispasmodics, antihistamines, and tricyclic antidepressants. Therefore, it is essential for patients to disclose all medications they are currently taking to their healthcare provider before starting this medication.
It is also important to avoid combining this medication with alcohol or other CNS depressants. This medication may increase the risk of heat stroke. Patients should be aware of these potential risks and take necessary precautions.
If you have any questions or concerns regarding the use of Oxybutynin Chloride 7.5 mg Slow Release Capsules, please do not hesitate to reach out to your healthcare provider for further information and guidance.
Oxybutynin Chloride 7.5 mg Slow Release Capsules are a specialized formulation designed to treat overactive bladder, a condition marked by urinary urgency, frequency, and urge incontinence. The active ingredient, oxybutynin chloride, is an anticholinergic medication that functions by inhibiting the action of acetylcholine, a neurotransmitter that triggers bladder contractions.
This slow release formulation is crafted with Methocel E4M, a type of controlled-release polymer. This innovative design allows for a gradual and sustained release of the active ingredient over an extended period. This ensures a more consistent level of medication in the body over a longer duration, offering sustained therapeutic effects. The slow release mechanism also reduces the dosing frequency, thereby improving patient compliance, particularly for medications requiring a controlled and prolonged release profile.
The slow release formulation of Oxybutynin Chloride 7.5 mg also helps to mitigate the risk of side effects associated with the medication. By maintaining a steady level of medication in the body, it minimizes the peaks and troughs often associated with immediate-release medications, thereby reducing the potential for side effects.
It is crucial to take Oxybutynin Chloride 7.5 mg Slow Release Capsules as directed by your healthcare provider. The capsules should be swallowed whole with a full glass of water. Consistency is key, so it's important to take the medication at the same time each day to maintain an even level of medication in the body. Additionally, drinking plenty of fluids throughout the day can help reduce the risk of side effects.
If you have any questions or concerns about Oxybutynin Chloride 7.5 mg Slow Release Capsules, don't hesitate to reach out. It's important to fully understand how this medication works and how it can help manage your condition.
Oxybutynin Chloride 7.5 mg Slow Release Capsules are a specialized formulation designed to gradually release the active ingredient over an extended period of time. This is achieved through the use of Methocel E4M, a controlled-release polymer. The slow release of the medication offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications that require a controlled and prolonged release profile.
These capsules are primarily used to treat conditions such as urinary frequency, urgency, and urge incontinence. In children aged 5 years and older, Oxybutynin Chloride 7.5 mg Slow Release Capsules may be used to decrease the number of episodes of nocturnal enuresis.
Another potential use for these capsules is in the reduction of episodes of urinary incontinence in patients with neurogenic detrusor overactivity. However, it is crucial to note that Oxybutynin Chloride 7.5 mg Slow Release Capsules should not be used in patients with glaucoma, urinary retention, or gastric retention due to potential adverse effects.
If you have any questions about the use of Oxybutynin Chloride 7.5 mg Slow Release Capsules for any other condition, it is recommended to consult with a healthcare professional to ensure safe and appropriate use.
Oxybutynin Chloride 7.5 mg Slow Release Capsules is a medication that is encapsulated in a controlled-release polymer, Methocel E4M. This formulation is designed to gradually release the active ingredient over an extended period of time.
The slow release formulation offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, especially for medications requiring a controlled and prolonged release profile.
Methocel E4M is a type of controlled-release polymer used in the formulation of certain medications. It is designed to gradually release the encapsulated medication over an extended period of time.
The slow release mechanism works by gradually releasing the active ingredient of the medication over an extended period of time. This is achieved through the use of a controlled-release polymer, Methocel E4M, in the formulation of the capsules.
The frequency of dosing will depend on your doctor's prescription. However, the slow release formulation is designed to reduce the frequency of dosing, making it more convenient for patients.
Reduced dosing frequency can improve patient compliance, as it is easier to remember to take the medication. It also ensures a sustained therapeutic effect as the medication is gradually released over an extended period of time.
No, the capsules should not be broken or chewed. Doing so can interfere with the controlled-release mechanism and may lead to the rapid release of the medication, which can increase the risk of side effects.
If you miss a dose, take it as soon as you remember. However, if it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.
Side effects can vary from person to person and should be discussed with your healthcare provider. Common side effects may include dry mouth, dizziness, and constipation. If any of these effects persist or worsen, notify your doctor promptly.
Before starting any new medication, it is important to discuss with your healthcare provider. Some medications may interact with Oxybutynin Chloride 7.5 mg Slow Release Capsules, affecting how it works or increasing the risk of side effects.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
